PUMA BIOTECHNOLOGY INC's ticker is PBYI and the CUSIP is 74587V107. A total of 70 filers reported holding PUMA BIOTECHNOLOGY INC in Q2 2023. The put-call ratio across all filers is 0.13 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,246,554 | -25.4% | 473,975 | +0.2% | 0.20% | -11.3% |
| Q2 2023 | $1,669,937 | +14.2% | 473,070 | 0.0% | 0.23% | +21.7% |
| Q1 2023 | $1,461,786 | -38.5% | 473,070 | -15.8% | 0.19% | -48.1% |
| Q4 2022 | $2,375,606 | +79.0% | 561,609 | +0.3% | 0.36% | +30.0% |
| Q3 2022 | $1,327,000 | -19.7% | 559,769 | -3.5% | 0.28% | -33.6% |
| Q2 2022 | $1,653,000 | -12.2% | 579,915 | -11.3% | 0.42% | -30.8% |
| Q1 2022 | $1,882,000 | -9.4% | 653,445 | -4.4% | 0.61% | -45.1% |
| Q4 2021 | $2,078,000 | – | 683,619 | – | 1.11% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Cormorant Asset Management, LP | 207,500 | $21,609,000 | 4.97% |
| WEATHERBIE CAPITAL, LLC | 250,296 | $26,066,000 | 2.47% |
| Redmile Group, LLC | 172,092 | $17,922,000 | 2.14% |
| Tekla Capital Management LLC | 185,820 | $19,351,000 | 1.93% |
| Iguana Healthcare Management, LLC | 35,000 | $3,645,000 | 1.68% |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | 5,686,668 | $592,210,000 | 1.62% |
| Atika Capital Management LLC | 11,350 | $1,182,000 | 1.01% |
| Eventide Asset Management | 44,900 | $4,676,000 | 0.73% |
| Ghost Tree Capital, LLC | 11,330 | $1,180,000 | 0.70% |
| BB BIOTECH AG | 117,991 | $12,288,000 | 0.63% |